The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
Jingjia Cao, Xiaolu Zhu, Yaru Sun, Xiao Li, Canhua Yun, Wei Zhang
Topics & Concepts
Papillary thyroid cancerMedicineMutationRefractory (planetary science)V600EInternal medicineThyroid cancerOncologyRadioiodine therapyCancer researchGastroenterologyThyroidBiologyGeneGeneticsAstrobiologyThyroid Cancer Diagnosis and TreatmentThyroid Disorders and TreatmentsThyroid and Parathyroid Surgery